Download Classical Swine Fever (CSF) is regarded as one of the

News from Boehringer Ingelheim Svanova:
New porcine test complements the panel for
monitoring highly infectious diseases
30th June 2014
The Swedish veterinary diagnostic company, Boehringer Ingelheim Svanova
now presents a new ELISA test kit. The kit detects antibodies to Classical Swine
Fever Virus (CSFV) and is a valuable tool for monitoring exposure to this
important virus.
Classical Swine Fever (CSF) is regarded as one of the most important diseases threatening
industrialized pig production. CSFV occurs in many regions worldwide, some countries have
eradicated the disease, yet it keeps recurring sporadically.
Endemic CSFV infections in feral pigs are an important threat to domestic pigs and are a
major source for the reintroduction of CSFV. Veterinary laboratories will have now with
SVANOVIR®CSFV-Ab a reliable tool for monitoring infection in domestic and feral pigs.
Well demonstrated performance
The high performance of SVANOVIR®CSFV-Ab has been demonstrated on an OIE compliant
serum panel from the Community Reference Laboratory (CRL) Hannover. Here SVANOVIR®
CSFV-Ab detected antibodies to high, medium and low virulent strains, in sera of
convalescent pigs and during early phase of infection. Cross-reactivity to non-CSF/ruminant
Pestivirus (BVDV/BDV) that can occasionally be detected in pigs was very low, thus the assay
fulfils the requirements set by OIE. Additionally, quality control data demonstrate a high
robustness of the assay which is essential for delivering accurate results to producers,
veterinarians and governmental bodies.
One of several test kits
This well balanced assay will be a reliable tool, on a representative sample size, to
demonstrate population freedom from infection, in trading situations and surveillance
programmes. In areas controlling CSFV by vaccination, the assay enables the detection of
antibodies generated by vaccination.
Boehringer Ingelheim Svanova offers further assays for controlling other highly infectious
diseases of pigs i.e. for Aujeszky disease (SVANOVIR® PRV gE-Ab, SVANOVIR® PRV gB-Ab),
African Swine Fever Virus (SVANOVIR® ASFV-Ab) and Coronavirus infections (SVANOVIR®
TGEV/PRCV-Ab).
For additional information please contact
Claudia Lindh, Brand Manager
Or visit our website www.svanova.com